The rising prevalence of AmpC β-lactamase, MBL, and ESBL-producing isolates reflects a worrying trend of escalating resistance mechanisms in bacteria, which poses a serious challenge to the effectiveness of current antimicrobial therapies [ 27 ].
← all excerpts
Unveiling the Silent Threat: The Rise of Β-Lactamase Enzymes in Gram-Negative Bacterial Isolates Identified From Sterile Body Fluids in an Indian Healthcare Institution.
1
—
—